Gossamer Bio
GOSS
157 hedge funds and large institutions have $1.02B invested in Gossamer Bio in 2022 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 13 closing their positions.
231% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 13
176% more capital inflows, than outflows
Capital inflows: $423M | Capital outflows: $153M
161% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $6.58M
84% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 31
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
24% more funds holding
Funds holding: 127 → 157 (+30)
8.11% more ownership
Funds ownership: 82.59% → 90.7% (+8.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EcoR1 Capital
San Francisco,
California
|
+$51.6M |
| 2 |
NEA Management Company
Timonium,
Maryland
|
+$43M |
| 3 |
Cormorant Asset Management
Boston,
Massachusetts
|
+$37.2M |
| 4 |
Weiss Asset Management
Boston,
Massachusetts
|
+$34.4M |
| 5 |
VR Adviser
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$24.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$19.3M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$16.5M |
| 4 |
Emerald Advisers
Leola,
Pennsylvania
|
-$15.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12M |
GOSS Hedge Fund Activity: Q3 2022 in Review
157 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2022, worth a combined $1.02B — up 91% from $533M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new GOSS positions and 13 closed out — a net gain of 30 holders — while 57 added to existing stakes and 31 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $51.6M. The largest seller was Kynam Capital Management, cutting an estimated $24.4M.
- 157 institutional investors held Gossamer Bio (GOSS) as of Q3 2022, up from 127 in Q2 2022.
- Funds reported $1.02B of Gossamer Bio stock for Q3 2022, up 91% quarter-over-quarter.
- 43 funds opened new Gossamer Bio positions in Q3 2022 and 13 closed out, a net change of +30 holders.
- The largest Gossamer Bio buyer in Q3 2022 was EcoR1 Capital, an estimated $51.6M added.
- The largest Gossamer Bio seller in Q3 2022 was Kynam Capital Management, an estimated $24.4M sold.
Based on aggregated 13F filings for Q3 2022.